 Skeletal integrity premenopausal postmenopausal women long-term L-thyroxine therapy PURPOSE impact long-term L-thyroxine replacement therapy skeletal integrity concern large number women thyroid hormone therapy purpose study hypothesis long-term L-thyroxine therapy free thyroxine index physiologic range minimal impact vertebral femoral mineral density premenopausal postmenopausal women PATIENTS METHODS hip integral spinal trabecular integral bone densities premenopausal postmenopausal women L-thyroxine therapy median years therapy normal range relationship bone density parameters hormone status univariate multivariate statistical methods RESULTS Seventy-nine percent premenopausal women postmenopausal women values normal range time bone density determination study duration majority values normal range subjects Premenopausal women bone density age mean SD spinal trabecular spinal integral hip integral bone density Postmenopausal women bone density values significant hip spinal trabecular spinal integral hip integral bone density patients Graves disease group differences bone density hip Correlation analysis weak nonsignificant relationships parameters thyroid hormone status bone density site subgroup Results multiple regression analysis data subjects age significant contribution variability bone density spine hip parameters thyroid hormone status CONCLUSION data first supportive evidence long-term L-thyroxine therapy physiologic range significant minimal decrement spinal hip bone density premenopausal postmenopausal women decrement hip due inclusion patients treated Graves diseases changes bone density women long-term L-thyroxine therapy contraindication therapy